Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jancin B - The investigational long-acting interleukin-1 inhibitor rilonacept showed potential as an important new treatment option in patients with severe refractory chronic active gout in a small pilot study, according to a rheumatologist whose research focus is chronic gout.

Related Articles

Outcome Domains for Studies of Acute and Chronic Gout
Journal of Rheumatology, 10/20/09    Relevance Score: 68%

Progress in Measurement Instruments for Acute and Chronic Gout Studies
Journal of Rheumatology, 10/23/09    Relevance Score: 67%

New Phase II data show ACZ885 gave better pain relief and flare prevention for patients with chronic gout than an injectable corticosteroid
Novartis, 10/21/09    Relevance Score: 65%

Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09    Relevance Score: 63%

T-Cell Recognition of Prostatic Peptides in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
The Journal of Urology, 10/14/09    Relevance Score: 47%

Today in Gout and Hyperuricemia...keeping you current

Crystal-induced neutrophil activation
Immunology & Cell Biology, 12/09/09

Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09

The modern management of gout
Rheumatology, 10/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address